- Bullseye Trades
- Posts
- Med-X is preparing for a possible NASDAQ listing (ticker: MXRX)
Med-X is preparing for a possible NASDAQ listing (ticker: MXRX)
See which E-commerce GIANTS are already on board...

*together with Med-x Inc.
Med-X is preparing for a possible NASDAQ listing (ticker: MXRX). But the real opportunity is now β before global validation changes everything.
In independent lab studies, Med-X's all-natural pesticides have outperformed chemical brands in certain use cases, delivering powerful results without the toxic tradeoffs associated with traditional pest control.
Now, Med-X is pursuing a potential milestone that could redefine the industry: becoming the first botanical pesticide ever pre-qualified by the World Health Organization.
The global biopesticide market is projected to grow nearly 3x by 2030, expanding from $5.8 billion to $17.6 billion as governments move away from synthetic chemicals. A WHO pre-qualification would position Nature-Cide as a globally recognized solution for public health, agriculture, and mosquito-borne disease control β opening doors that most pesticide companies can't access.
Nature-Cide's plant-based formulation prioritizes safety while delivering industrial-grade performance, challenging long-held assumptions about what botanical solutions can achieve on a global scale.
NASDAQ Ticker: MXRX Reserved!
The Real Opportunity to Become a Shareholder Is Now!
Med-X has earned national and international recognition for providing effective alternatives to conventional pesticides across residential, commercial, agricultural, and public-health sectors. Proudly manufactured in the USA, Nature-Cide reflects a commitment to scalable, sustainable innovation.
Already sold through eCommerce giants Amazon, Walmart, and Kroger, and expanding into 41 international markets, Med-X is positioning itself for its next major chapter.
Simpler. Safer. More Effective Pesticides.
Med-X Disclosures:
This is a paid advertisement for Med-X's Regulation A+ Offering.
Please read the offering circular at invest.medx-rx.com
DISCLAIMER: This entity is owned by Sherwood Ventures LLC (SV). Full disclaimer https://bullseyealerts.com/disclaimer/. We are a financial publisher, not a registered investment advisor. Our content is for informational purposes only and should not be considered personalized investment advice. All trading involves substantial risk of loss and you may lose some or all of your invested capital. Past performance does not guarantee future results.
*PAID PROMOTION: Sherwood Ventures has been compensated two thousand four hundred fifty dollars for this communication (via IMS) to increase public awareness of Med-x Inc. We are not currently invested in the company. We recommend that you do your own independent research before investing in anything, as private investing is risky and often illiquid. We believe in the companies we form affiliate relationships with, but please donβt invest any money unless you believe it will help you achieve your goals. SV is not responsible for any content hosted on third-party sites or your experience with third-party advertisers. It is the third party's responsibility to ensure compliance with applicable laws. We make no guarantees or warranties about what is advertised and have no fiduciary duty to subscribers. Always consult a qualified financial professional before making investment decisions.
